Silibinin Modulates NF-κB Activation and Heat Shock Protein in Preeclampsia-Like Rat Model

Area of Science:

• Reproductive biology and toxicology
• Pharmacology and natural product research

Background:

• Preeclampsia (PE) is a complex hypertensive disorder of pregnancy.
• PE pathophysiology involves placental oxidative stress and inflammation.
• Silibinin, a flavonoid, possesses antioxidant and anti-inflammatory properties.

Purpose of the Study:

• To investigate silibinin's preventive effects on N-nitro-L-arginine methyl ester (L-NAME)-induced preeclampsia in rats.
• To explore silibinin's potential as an anti-inflammatory agent for PE prevention.

Main Methods:

• Pregnant Wistar rats were induced with PE using L-NAME.
• Silibinin treatment was administered at different gestational stages (days 0, 7, or 14).
• Evaluated blood pressure, proteinuria, weight gain, and inflammatory markers (TNF-α, IL-1β, IFN-γ, Hsp70, NF-κB) in liver and placenta.

Main Results:

• Silibinin treatment significantly reduced levels of inflammatory cytokines (TNF-α, IL-1β, IFN-γ) and Hsp70 in liver and placenta.
• NF-κB activation was decreased in silibinin-treated groups, particularly when treatment started early.
• Silibinin demonstrated a preventive effect in this PE-like model.

Conclusions:

• Silibinin acts as a preventive agent in a PE-like rat model, mirroring key human PE features.
• The findings suggest silibinin modulates crucial inflammatory and stress pathways relevant to PE.
• Silibinin shows translational potential for preeclampsia prevention.